New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Genelux Corporation
GNLX
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

95M

Biotechnology

Next Earning date - 12 Nov 2024

95M

Biotechnology

Next Earning date - 12 Nov 2024

2.75USD
Shape-0.06 ( -2.14%)
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-18%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

86%

Quote Panel

Shape
Updated October 21, 2024
1W -13.79 % 1M 27.91 % 3M 25.57 % 1Y -85.84 %

Key Metrics

Shape
  • Market Cap

    94.97M


  • Shares Outstanding

    34.54M


  • Share in Float

    27.77M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    2.75


  • Average Volume

    148073


  • Beta

    -3.16514


  • Range

    1.6-20.25


  • Industry

    Biotechnology


  • Website

    https://www.genelux.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

64.52x

P/S Ratio

2.17x

P/B Ratio

0.1

Debt/Equity

-1802.9%

Net Margin

$-0.9

EPS

How GNLX compares to sector?

P/E Ratio

Relative Strength

Shape

GNLX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$97K

ShapeNaN%

2025-Revenue

$0.97

Shape-343%

2025-EPS

$35K

Shape101%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Brookline Capital

upgrade

Previous: Not converted

2023-10-31

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+212%

0.16
vs -0.14

Q4.22

arrow
arrow

N/A

-0.13
vs -0.12

Q1.23

arrow
arrow

N/A

-0.59
vs -0.13

Q2.23

arrow
arrow

N/A

-0.23
vs -0.13

Q3.23

arrow
arrow

N/A

-0.20
vs 0.16

Q4.23

arrow
arrow

N/A

-0.25
vs -0.13

Q1.24

arrow
arrow

N/A

-0.29
vs -0.59

Q2.24

arrow
arrow

N/A

-0.22
vs -0.23

Q3.24

arrow
arrow

N/A

-0.19
vs -0.20

Q4.24

arrow
arrow

N/A

-0.20
vs -0.25

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

11M  vs NA

Q4.22

arrow
arrow

NA

68K  vs NA

Q1.23

arrow
arrow

NA

170K  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

-100%

NA  vs 11M

Q4.23

arrow
arrow

+2053%

1.5M  vs 68K

Q1.24

arrow
arrow

-95%

8K  vs 170K

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-15%

-0.15
vs 0.07

Q4.22

arrow
arrow

+9%

0.09
vs -0.15

Q1.23

arrow
arrow

-535%

-5.35
vs 0.09

Q2.23

arrow
arrow

-26%

-0.26
vs -5.35

Q3.23

arrow
arrow

-22%

-0.22
vs -0.26

Q4.23

arrow
arrow

-35%

-0.35
vs -0.22

Q1.24

arrow
arrow

-52%

-0.52
vs -0.35

Q2.24

arrow
arrow

-17%

-0.17
vs -0.52

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News